Clinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
NCT03560271 is registered in ClinicalTrials.gov with NovMetaPharma Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
- Lead sponsor
- NovMetaPharma Co., Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 18, 2018
- Completion date
- July 15, 2019
- Enrollment
- 256 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.